Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Common Cents Systems and Translational Software Improve Efficiency in Pharmacogenetic Testing

Published: Tuesday, February 04, 2014
Last Updated: Tuesday, February 04, 2014
Bookmark and Share
The collaboration combines Apollo’s platform for operational excellence with Translational Software’s PGx decision support system.

Common Cents Systems, Inc.(ApolloLIMS) and Translational Software have successfully collaborated to improve Pharmacogenetic (PGx) testing and reporting processes. This strategic collaboration combines Apollo’s platform for operational excellence with Translational Software’s PGx decision support system to enable their customers to improve turnaround time, decrease errors, and make test results more relevant for clinicians.

There is a rapid adoption of pharmacogenetic testing in laboratories across the nation as clinicians recognize the value of genetic testing. As a result, laboratories are producing large amounts of complex genetic data. To interpret the genetic data into actionable medical information a pharmacogenetic knowledgebase is needed. Typically a clinical laboratory does not have the dedicated resources available to develop a knowledgebase or the IT resources to link the laboratory and knowledgebase together.

The ApolloLIMS Lab Automation component gives the lab automated programmatic processes that intelligently send and receive data directly with the laboratory testing equipment without requiring data entry by the operator.  By combining that with the Apollo eXchange HL7 Interface engine, the companies have been successful in creating a bi-directional seamless integration from the pre-analytic, analytic, and post-analytic phases.  The interface with the Translational Knowledgebase adds the interpretive phase and highly configurable report designs to the integration. Many laboratories have already seen the benefits of this collaboration in terms of elimination of duplicate data entry, streamlined work flow resulting in decreased turnaround time and improved customer satisfaction.

Rob Ringenberg, president of Common Cents Systems, Inc., sees the value that can be delivered to customers through the collaboration.  "Laboratory automation is key to efficiency in the modern laboratory.  ApolloLIMS excels at delivering a high level of automation through instrument interfaces, foreign system interfaces and web products.  By working directly with the senior staff at Translational Software we have been able to greatly reduce the project timeline and deliver a superior end product.”

Until recently, clinical adoption of genomic testing has been inhibited by the massive amounts of data, challenging analysis, and the difficulty of adapting research technologies to the clinical setting. Don Rule, Translational’s founder and CEO, says “we recognized that there was an opportunity to augment current solutions that required knowledge of genetics, pharmacology, and informatics. By combining these skill sets we’ve developed a system that enables diagnostic laboratories to bring pharmacogenetic testing to the market dramatically faster.”
This alliance marries a laboratory's need for intelligent software (like ApolloLIMS) and the extensive pharmacogenetic clinical decision support that Translational Software has to offer. A strategic partnership like this one could not have come at a better time for the laboratory world and the Return on Investment (ROI) by early adopters has already proven it to be successful.




Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
Shining A Light On Bladder Cancer
Researchers scrutinize patterns of mutations in bladder tumor genomes, gleaning insights into the roles of DNA repair and tobacco-related DNA damage.
Monovar Drills Down Into Cancer Genome
Rice, MD Anderson develop program to ID mutations in single cancer cells.
Autism, Cancer Share a Remarkable Number of Risk Genes
Researchers with the UC Davis Comprehensive Cancer Center, MIND Institute identify more than 40 common genes.
Number Of Known Genetic Risk Factors For Endometrial Cancer Doubled
An international collaboration of researchers has identified five new gene regions that increase a woman’s risk of developing endometrial cancer, one of the most common cancers to affect women, taking the number of known gene regions associated with the disease to nine.
Genetic Variant May Help Explain Why Labradors Are Prone To Obesity
A genetic variation associated with obesity and appetite in Labrador retrievers – the UK and US’s favourite dog breed – has been identified by scientists at the University of Cambridge. The finding may explain why Labrador retrievers are more likely to become obese than dogs of other breeds.
How Scientists Use DNA to Track Disease Outbreaks
They’re the top questions on everyone’s mind when a new disease outbreak happens: where did the virus come from? When did this happen? How long has it been spreading in a particular country or group of people?
Genetic Risk Factors of Disparate Diseases Share Similar Biological Underpinnings
Penn Institute for Biomedical Informatics and colleagues identify "roadmap" of disease mechanisms to identify candidate drug targets.
Stem Cells Know How to Unwind
Research led by the Babraham Institute with collaborators in the UK, Canada and Japan has revealed a new understanding of how an open genome structure supports the long-term and unrestricted developmental potential in embryonic stem cells.
Childhood Asthma Research Receives $2M
Research into the impact of a child’s upbringing and social and physical environments on the development of asthma will receive $2 million to tackle the condition that affects as many as one in three Canadians.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!